DEUTSCHE BANK AG\ - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 33 filers reported holding ACASTI PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q4 2019$190,000
+2614.3%
77,700
+1142.6%
0.00%
Q2 2019$7,000
-70.8%
6,253
-74.5%
0.00%
Q1 2019$24,000
-89.9%
24,500
-90.3%
0.00%
Q4 2017$238,000252,603
+117389.8%
0.00%
Q4 2015$02150.00%
Other shareholders
ACASTI PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Anson Funds Management LP 684,600$527,0000.31%
Perceptive Advisors 206,677$117,0000.00%
Virtu Financial LLC 41,066$23,0000.00%
INTACT INVESTMENT MANAGEMENT INC. 48,990$37,0000.00%
TORONTO DOMINION BANK 100$00.00%
MORGAN STANLEY 40,000$23,0000.00%
BANK OF MONTREAL /CAN/ 154,439$88,0000.00%
Citadel Advisors 32,648$19,0000.00%
BREWIN DOLPHIN LTD 30$170.00%
Renaissance Technologies 18,600$11,0000.00%
View complete list of ACASTI PHARMA INC shareholders